RHHVF (Roche Holding AG) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RHHVF Roche Holding AG RHHVF
79 GF Score
Price $450.50
GF Value $328.83
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

RHHVF
79GF Score
Roche Holding AG RHHVF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (RHHVF) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of $450.50 is trading 37% above its estimated GF Value™ of $328.83. GuruFocus considers Roche Holding AG to be Significantly Overvalued.

Key valuation signals for RHHVF:

  • FFO:
  • GF Value™: $328.83 vs. price of $450.50 (37% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the RHHVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
79GF Score

Get the complete analysis for RHHVF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$450.50
Price
$328.83
GF Value